What patient characteristics prompt you to prescribe vericiguat for patients with heart failure with reduced ejection fraction who are already on standard therapy?

When considering the addition of vericiguat for patients with HFrEF who are already on standard therapy, several patient characteristics guide my decision-making process:

1. Recent Decompensation: I particularly consider vericiguat for patients who have experienced a recent episode of heart failure decompensation, such as a hospitalization or the need for intravenous diuretics. Vericiguat has shown benefits in reducing the risk of cardiovascular death and heart failure hospitalization in patients ...